Skip to content
  • Sunday, 26 July 2026
  • 3:05 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease Research
Molecular & Cell Biology

DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease Research

Angie Faith Jun 19, 2026 0

One of the most significant hurdles in unraveling the complexities of aging and a spectrum of diseases lies in the…

Read More
Molecular & Cell Biology

DNA Aptamers Offer Breakthrough in Identifying Senescent Cells, Paving the Way for New Aging and Disease Treatments

Angie Faith May 30, 2026 0

The persistent challenge of precisely identifying senescent cells, often referred to as "zombie cells," has long been a significant hurdle…

Read More
Molecular & Cell Biology

Unlocking the Secrets of Senescent Cells: DNA Aptamers Offer a Breakthrough in Aging and Disease Research

Angie Faith May 23, 2026 0

One of the most formidable hurdles in the relentless pursuit of understanding and combating age-related diseases lies in accurately identifying…

Read More
Molecular & Cell Biology

Revolutionary DNA Aptamers Offer New Hope in Identifying Elusive Senescent Cells

Angie Faith May 15, 2026 0

One of the most persistent and formidable challenges in the relentless pursuit of understanding aging and its associated diseases lies…

Read More
Laboratory Automation & Robotics

Rubedo Life Sciences Pivots from Cosmetic Enhancement to Biological Rejuvenation with Senescent Cell Clearance for Age-Related Skin Conditions

Lana Keisha Apr 7, 2026 0

Dr. Frederick Beddingfield III, a seasoned pharmaceutical executive known for his instrumental role in scaling Botox into a multi-billion-dollar franchise…

Read More
Laboratory Automation & Robotics

Rubedo Life Sciences Charts Ambitious Course to Reverse Skin Aging and Disease Through Targeted Senescent Cell Clearance

Lana Keisha Mar 30, 2026 0

In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…

Read More
Beyond the Neuron: How Star-Shaped Astrocytes Regulate Fear Memory and Processing in the BrainAalto University Researchers Develop Quantum-Inspired Algorithm to Solve Massive Materials Science Problems and Advance Quantum ComputingScience News: A Century of Empowering Public Understanding of ScienceProfessor Peter Tessier Pioneers AI-Driven Solutions for Antibody Deliverability Challenges
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ